Optimizing the tumor shrinkage threshold for evaluating immunotherapy efficacy for advanced non-small-cell lung cancer.

Wei DuChen ChenLin-Feng LuoLi-Na HeYixing WangXuanye ZhangYixin ZhouZuan LinShaodong Hong

Published in: Journal of cancer research and clinical oncology (2022)

10% SLD change score could discriminate for ICIs treatment response, which holds great promise in promoting the development of precise immunotherapeutic strategy.

Keyphrases

advanced non small cell lung cancer
epidermal growth factor receptor
big data
tyrosine kinase